The unified social credit code/registration number of Dalian Feng Yali Biopharmaceutical Co., Ltd. is 91210200732786053b, and the enterprise is in the state of opening.
The business scope of Dalian Feng Yali Biopharmaceutical Co., Ltd. is: biotechnology development and consulting services; Production of influenza virus split vaccine; Production of rabies vaccine for human use (Vero cells); SARS vaccine research (involving administrative license, it must be operated with a license), import and export business of goods and technologies (except for the distribution business of imported goods) (except for projects prohibited by laws and administrative regulations, and projects restricted by laws and administrative regulations can only be operated after obtaining a license). * * * (Projects subject to approval according to law can only be operated after being approved by relevant departments. )。 In Liaoning province, the total registered capital of companies with similar business scope is 2,398.33 million yuan, and the main capital is concentrated in enterprises with more than 50 million yuan and100-50 million yuan, with 8 1. In the province, the registered capital of enterprises is excellent.
See more information and materials of Dalian Feng Yali Biopharmaceutical Co., Ltd. through Baidu Enterprise Credit.